BACKGROUND: A clustering of insulin resistance, hypertension, and dyslipidemia has been labeled as metabolic syndrome. Asians have a lower frequency of obesity than do Caucasians but have an increasing tendency toward metabolic syndrome. METHODS: We conducted a cross-sectional study of individuals aged 30-60 years. We analyzed the health data of 596 Japanese and Mongolians for metabolic syndrome based on the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) definition and the three modified ATP III definitions. RESULTS: The prevalence of metabolic syndrome using ATP III criteria was 6% for the Japanese and 12% for the Mongolians, a remarkable lower prevalence relative to the reported prevalence in the United States. With the exception of visceral obesity, the prevalences of individual metabolic abnormalities within each of the two Asian groups were similar to each other and to reported rates of prevalence in the United States. CONCLUSIONS: A universal metabolic syndrome definition is inappropriate for comparisons of metabolic syndrome among Asian ethnic groups. We believe that the ATP III index for visceral obesity should be adjusted for Asian populations.
BACKGROUND: A clustering of insulin resistance, hypertension, and dyslipidemia has been labeled as metabolic syndrome. Asians have a lower frequency of obesity than do Caucasians but have an increasing tendency toward metabolic syndrome. METHODS: We conducted a cross-sectional study of individuals aged 30-60 years. We analyzed the health data of 596 Japanese and Mongolians for metabolic syndrome based on the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) definition and the three modified ATP III definitions. RESULTS: The prevalence of metabolic syndrome using ATP III criteria was 6% for the Japanese and 12% for the Mongolians, a remarkable lower prevalence relative to the reported prevalence in the United States. With the exception of visceral obesity, the prevalences of individual metabolic abnormalities within each of the two Asian groups were similar to each other and to reported rates of prevalence in the United States. CONCLUSIONS: A universal metabolic syndrome definition is inappropriate for comparisons of metabolic syndrome among Asian ethnic groups. We believe that the ATP III index for visceral obesity should be adjusted for Asian populations.
Authors: Eva Pardina; Roser Ferrer; Juan Antonio Baena-Fustegueras; Joaquín Rivero; Albert Lecube; Jose Manuel Fort; Víctor Vargas; Roberto Catalán; Julia Peinado-Onsurbe Journal: Obes Surg Date: 2012-01 Impact factor: 4.129
Authors: Subhashish Agarwal; David R Jacobs; Dhananjay Vaidya; Christopher T Sibley; Neal W Jorgensen; Jerome I Rotter; Yii-Der Ida Chen; Yongmei Liu; Jeanette S Andrews; Stephen Kritchevsky; Bret Goodpaster; Alka Kanaya; Anne B Newman; Eleanor M Simonsick; David M Herrington Journal: Cardiol Res Pract Date: 2012-03-21 Impact factor: 1.866
Authors: Seong Ho Lee; Sang Kon Lee; Min Soo Choo; Kyung Tae Ko; Tae Young Shin; Won Ki Lee; Tsolmon Batsaikhan; ShanAi Quan; Jin Young Jeong; Dong Hyun Kim Journal: Biomed Res Int Date: 2015-06-23 Impact factor: 3.411